India Pharma Outlook Team | Wednesday, 10 September 2025
Tata Elxsi, a global leader in design and technology services, announced the inauguration of the ‘Bayer Development Centre in Radiology’ at Tata Elxsi, Pune, India.
The center is designed to co-develop with Bayer, a leader in key areas of radiology, advanced radiology devices, and technology that enable early and accurate diagnosis and treatment of serious illnesses, supporting Bayer’s global mission to bring innovative, safe, and compliant solutions to patients and clinical staff worldwide.
This center will provide a wide range of engineering for complex radiology devices, with an initial focus on molecular imaging. The facility’s integrated approach, which combines design, development, and validation, will help accelerate time-to-market, enhance cost efficiency, and help deliver new technology to market fast, efficiently, and at an optimized cost, while meeting the highest regulatory compliance standards.
Also Read: Sun Pharmas Halol Plant Receives OAI Status from USFDA Inspection
This collaboration leverages Tata Elxsi’s healthcare engineering expertise and the strength of the Tata and India ecosystems, enabling access to advanced labs, regulatory partnerships, and specialized technology talent. This creates a scalable foundation for innovation and strengthens Bayer’s ability to deliver radiology solutions across multiple geographies, including the US and EU.
Dr Konstanze Diefenbach, head of research & development, radiology, Bayer, said, “Bayer is committed to innovative products and high-quality services in diagnostic imaging, and device innovation plays a critical role in delivering precision and safety in patient care. This new center gives us direct access to specialized engineering capabilities through Tata Elxsi, enabling us to accelerate our pipeline of advanced radiology devices while maintaining the quality and reliability that healthcare providers expect from Bayer.”
